Analyst consensus rating
Entera Bio Analyst Rating: Strong Buy
Direct answer
Entera Bio's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.75.
Forecast evidence checked October 19, 2026.
Get free Entera Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.68
- Average price target
- $9.75
- High price target
- $11.00
- Low price target
- $9.00
- Low target gap
- +235.8%
- Target upside
- +263.8%
- High target gap
- +310.4%
- Target range width
- 74.6%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Entera Bio?
Entera Bio has a verified Strong Buy consensus. The same dataset has an average price target of $9.75.
How far are Entera Bio's low and high targets from the recorded price?
The low target implies +235.8%, while the high target implies +310.4%.
How many analysts are included in Entera Bio's consensus?
The verified consensus includes 4 analysts.
How is Entera Bio's target upside or downside calculated?
The average target of $9.75 is divided by the recorded price of $2.68, then one is subtracted to produce +263.8%. This does not guarantee a future return.
When was Entera Bio's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.